Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele. - Archive ouverte HAL Access content directly
Journal Articles British Journal of Clinical Pharmacology Year : 2010

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

(1) , (1, 2) , (1, 3) , (1) , (4, 5) , (2) , (1, 2) , (1, 3) , (1, 6)
1
2
3
4
5
6

Abstract

AIM: In renal transplant patients given mycophenolate mofetil (MMF), we investigated the relationship between the digestive adverse events and polymorphisms in the UGT genes involved in mycophenolic acid (MPA) intestinal metabolism and biliary excretion of its phase II metabolites. METHODS: Clinical data and DNA from 256 patients transplanted between 1996 and 2006 and given MMF with cyclosporin (CsA, n = 185), tacrolimus (TAC, n = 49) or sirolimus (SIR, n = 22), were retrospectively analysed. The relationships between diarrhoea and polymorphisms in UGT1A8 (2; 518C>G, 3; 830G>A), UGT1A7 (622C>T), UGT1A9 (-275T>A), UGT2B7 (-840G>A) and ABCC2 (-24C>T, 3972C>T) or the co-administered immunosuppressant were investigated using the Cox proportional hazard model. RESULTS: Multivariate analysis showed that patients on TAC or SIR had a 2.8 higher risk of diarrhoea than patients on CsA (HR = 2.809; 95%CI (1.730, 4.545); P < 0.0001) and that non-carriers of the UGT1A8 2 allele (CC518 genotype) had a higher risk of diarrhoea than carriers (C518G and 518GG genotypes) (HR = 1.876; 95%CI (1.109, 3.175); P = 0.0192). When patients were divided according to the immunosuppressive co-treatment, a significant effect of UGT1A8 2 was found in those co-treated with CsA (HR = 2.414; 95%CI (1.089, 5.354); P = 0.0301) but not TAC or SIR (P = 0.4331). CONCLUSION: These results suggest that a possible inhibition of biliary excretion of MPA metabolites by CsA and a decreased intestinal production of these metabolites in UGT1A8 2 carriers may be protective factors against MMF-induced diarrhoea.
Fichier principal
Vignette du fichier
Woillard_et_al_manuscript_BJCP.pdf (210.31 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-00446912 , version 1 (07-02-2011)

Identifiers

Cite

Jean-Baptiste Woillard, Jean-Philippe Rerolle, Nicolas Picard, Annick Rousseau, Mireille Drouet, et al.. Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.: Pharmacogenetics of mycophenolate-induced diarrhea. British Journal of Clinical Pharmacology, 2010, 69 (6), pp.675-83. ⟨10.1111/j.1365-2125.2010.03625.x⟩. ⟨inserm-00446912⟩
151 View
450 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More